[ad_1]
«Don’t limit your dreams. This world can be yours, but to achieve tomorrow’s dreams, focus on getting the job done right today. Make mediocrity your enemy». That was his message Albert Mockery to his students AUTH, during the award ceremony of an honorary doctorate, in December 2019.
«You set the bar high every day. Not on average. But in the best previous jump. Κι When you get over it, raise the bar. “Over and over again,” Dr. Bourla said, addressing faculty and staff when it was announced. Doctor Honoris Causa of the Department of Medicine of the Faculty of Health Sciences of the AUTh, on December 18, 2019.
On Monday, Pfizer and BioNTech announced a “90% effective” coronavirus vaccine, with the director of the World Health Organization, Tentros Antanom Gebregesous, speaking of “encouraging news”.
Having erased a brilliant career that led him to the helm of one of the largest pharmaceutical companies in the world, Pfizer, admitted in his speech that AUTh’s contribution to your success exceeds the limits of scientific knowledge As professors and fellow students, he shaped his personality from the ages of 18 to 28, the decade in which he attended college.
“Aristotle shaped my character and completed my personality in the most critical decade of my life. From 18 to 28 years old. Within him I not only acquired knowledge, but mainly culture, values and ideals, which made me what I am and what They led me to where I am today.
In his talk on “Reflections on the future of biopharmaceutical research”, he highlighted the importance of innovative drugs and therapies to improve life expectancy and quality of life for patients. , highlighting the advances in cancer treatment.
Dr. Bourla was born and raised in Thessaloniki. I study in Veterinary school from Aristotle University of Thessaloniki, from which he graduated in 1986.
Complete it doctoral thesis of 1991 in the same School, in his subject Reproductive biotechnology, under the direction of the late Professor Pavlos Tsakalov.
From the AUTh seats on top of Pfizer
Dr. Μπουρλά He started his career at Pfizer in Greece in 1993 and three years later he moved to Brussels to pursue an international career, during which time he worked on five continents and lived in eight different cities, five different countries.
In 2001 he moved to the United States, where he assumed the position of Marketing Director. In 2006 he returned to Europe and became President of the European section of the Paris-based company, and was later appointed Director of Asia, Africa and the Pacific.
In 2010 he returned to New York as head of the “established products” department. In 2014 he took over President of the Department of Oncology Products and Vaccines and two years later he was designated as responsible for innovative products tfrom Pfizer.
In 2018 he was appointed Director of Operations and was elected a member of the company’s Board of Directors. During his tenure in this position, he led the commercial, strategic and construction activities, as well as those related to the company’s product department with global coverage. At the same time, it served President of the Research Portfolio Priority Committee, of the senior executive committee, which allocates resources to Pfizer research projects annually.
In October 2018, he was elected Chief Executive Officer and assumed the position in January 2019. In the first seven months, as Chief Executive Officer, he carried out a series of business movements to redefine Pfizer as a biopharmaceutical company, based on research. Formed a joint venture between Pfizer Consumer Health and GlaxoSmithKline, creating the largest and most diversified organization in the field of health services in the world.
Finally, he promoted a new philosophy of internal values and put Pfizer on a path with the primary goal of growth and innovation, which change the lives of patients.
